Science & Enterprise subscription

Follow us on Twitter

  • Genny Cream for me, if I were there https://t.co/BQcWbr7yLh
    about 40 mins ago
  • As the race to produce and distribute Covid-19 vaccines intensifies, financing of this global public health project… https://t.co/pyDX0IWnCs
    about 6 hours ago
  • New post on Science and Enterprise: Infographic – Public Money Funds Covid-19 Vaccines https://t.co/1D2XLhUi4Z #Science #Business
    about 6 hours ago
  • Excellent analysis. Real example: a colleague I hired at Science mag is leaving her job to get a grad degree in IT. https://t.co/c0qnYW025H
    about 9 hours ago
  • Two biotechnology companies are collaborating on using the gene editing technique Crispr to create engineered immun… https://t.co/4lK4qD5p6m
    about 1 day ago

Please share Science & Enterprise

Cancer Immunotherapy Adapted for HIV

T-cell infected by HIV

A biotechnology company is adapting and licensing its immunotherapy process, originally designed for cancer, as a cure for HIV infections. . . . → Read More: Cancer Immunotherapy Adapted for HIV

Monthly HIV Drug Combo Approved by FDA

HIV released from cell

The Food and Drug Administration approved a drug regimen given once a month to control HIV infections, to replace daily antiretroviral medications. . . . → Read More: Monthly HIV Drug Combo Approved by FDA

Crispr Edits Out HIV-Like Genes from Monkey DNA

Kamel Khalili and Tricia Burdo

Researchers show the gene-editing technique Crispr can remove genes gained from infections similar to HIV in lab monkeys, as well as viral signals from their bodies. . . . → Read More: Crispr Edits Out HIV-Like Genes from Monkey DNA

Engineered Immune, Stem Cells Studied for HIV Cure

HIV released from cell

Academic and industry researchers are investigating engineered immune-system cells combined with stem cells as an immunotherapy to neutralize HIV viruses and cure infections. . . . → Read More: Engineered Immune, Stem Cells Studied for HIV Cure

FDA Blocks Monthly HIV Drug Combo

T-cell infected by HIV

The U.S. Food and Drug Administration rejected a combination of experimental and existing drugs given once a month to treat HIV. . . . → Read More: FDA Blocks Monthly HIV Drug Combo

FDA Approves Single Dual-Drug Pill for HIV

HIV released from cell

The Food and Drug Administration approved a daily pill with 2 drugs to lower viral loads in people with HIV, but who have not yet taken other HIV drugs. . . . → Read More: FDA Approves Single Dual-Drug Pill for HIV

Trial Testing Vaginal Ring, PrEP in Teens, Young Women

Vaginal ring and PrEP

A clinical trial is underway testing use and preferences for drugs or a medical device to prevent HIV infection among young women and teenage girls in Africa. . . . → Read More: Trial Testing Vaginal Ring, PrEP in Teens, Young Women

Patent Set for Long-Term Drug Capsules

Star-shaped drug delivery

Techniques for delivering drugs in capsule form that last a week or longer in the patient are expected to receive a patent soon from U.S. authorities. . . . → Read More: Patent Set for Long-Term Drug Capsules

Infographic – HIV Infections Growing in Eastern Europe

Chart: HIV cases in Europe

While much attention is focused on the continuing AIDS and HIV crisis in Africa, countries in Eastern Europe are also facing growing numbers of HIV infections. . . . → Read More: Infographic – HIV Infections Growing in Eastern Europe

Antibody Combination Shown to Suppress HIV

T-cell infected by HIV

Results from a small-scale clinical trial show a combination of antibodies can suppress the HIV virus for many weeks after stopping antiretroviral therapy. . . . → Read More: Antibody Combination Shown to Suppress HIV